Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Arbaclofen in fragile X syndrome: results of phase 3 trials.

Berry-Kravis E, Hagerman R, Visootsak J, Budimirovic D, Kaufmann WE, Cherubini M, Zarevics P, Walton-Bowen K, Wang P, Bear MF, Carpenter RL.

J Neurodev Disord. 2017 Jun 12;9:3. doi: 10.1186/s11689-016-9181-6. eCollection 2017.

2.

Antidepressants and Suicide Risk: A Comprehensive Overview.

Pompili M, Serafini G, Innamorati M, Ambrosi E, Giordano G, Girardi P, Tatarelli R, Lester D.

Pharmaceuticals (Basel). 2010 Aug 30;3(9):2861-2883. Review.

3.

Update on the Use of SSRIs and SNRIs with Children and Adolescents in Clinical Practice.

Jane Garland E, Kutcher S, Virani A, Elbe D.

J Can Acad Child Adolesc Psychiatry. 2016 Winter;25(1):4-10. Epub 2016 Feb 1. No abstract available.

4.

Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.

Kondo DG, Forrest LN, Shi X, Sung YH, Hellem TL, Huber RS, Renshaw PF.

Amino Acids. 2016 Aug;48(8):1941-54. doi: 10.1007/s00726-016-2194-3. Epub 2016 Feb 23.

5.

Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression.

Qiu J, Hu SY, Shi GQ, Wang SE.

Pharmacogn Mag. 2014 Oct;10(40):503-8. doi: 10.4103/0973-1296.141775.

6.

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report.

Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM.

Neuropsychiatr Dis Treat. 2014 Oct 31;10:2049-55. doi: 10.2147/NDT.S71056. eCollection 2014.

7.

Intervention in the context of development: pathways toward new treatments.

Veenstra-VanderWeele J, Warren Z.

Neuropsychopharmacology. 2015 Jan;40(1):225-37. doi: 10.1038/npp.2014.232. Epub 2014 Sep 3. Review.

8.

The impact of psychopharmacology on contemporary psychiatry.

Baldessarini RJ.

Can J Psychiatry. 2014 Aug;59(8):401-5. No abstract available.

9.

Long-term trend in pediatric antidepressant use, 1983-2007: a population-based study.

Meng X, D'Arcy C, Tempier R.

Can J Psychiatry. 2014 Feb;59(2):89-97. Review.

10.

Near infrared spectroscopy study of the frontopolar hemodynamic response and depressive mood in children with major depressive disorder: a pilot study.

Usami M, Iwadare Y, Kodaira M, Watanabe K, Saito K.

PLoS One. 2014 Jan 23;9(1):e86290. doi: 10.1371/journal.pone.0086290. eCollection 2014.

11.

The treatment of depressive disorders in children and adolescents.

Dolle K, Schulte-K├Ârne G.

Dtsch Arztebl Int. 2013 Dec 13;110(50):854-60. doi: 10.3238/arztebl.2013.0854. Review.

12.

Practitioner review: Dysphoria and its regulation in child and adolescent depression.

Kovacs M, Yaroslavsky I.

J Child Psychol Psychiatry. 2014 Jul;55(7):741-57. doi: 10.1111/jcpp.12172. Epub 2013 Nov 21. Review.

13.

The relationship between depressive symptoms and obstructive sleep apnea in pediatric populations: a meta-analysis.

Yilmaz E, Sedky K, Bennett DS.

J Clin Sleep Med. 2013 Nov 15;9(11):1213-20. doi: 10.5664/jcsm.3178.

14.

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.

Mitchell NC, Gould GG, Smolik CM, Koek W, Daws LC.

Front Pharmacol. 2013 Oct 28;4:131. doi: 10.3389/fphar.2013.00131. eCollection 2013.

15.

Evidence for the management of adolescent depression.

Lewandowski RE, Acri MC, Hoagwood KE, Olfson M, Clarke G, Gardner W, Scholle SH, Byron S, Kelleher K, Pincus HA, Frank S, Horwitz SM.

Pediatrics. 2013 Oct;132(4):e996-e1009. doi: 10.1542/peds.2013-0600. Epub 2013 Sep 16. Review.

16.

Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

Sparks JA, Duncan BL.

J Can Acad Child Adolesc Psychiatry. 2013 Aug;22(3):240-6.

17.

Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons.

Karanges EA, Kashem MA, Sarker R, Ahmed EU, Ahmed S, Van Nieuwenhuijzen PS, Kemp AH, McGregor IS.

Front Pharmacol. 2013 Jul 8;4:86. doi: 10.3389/fphar.2013.00086. eCollection 2013.

18.

A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.

Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.

Arch Gen Psychiatry. 2012 May;69(5):515-28. doi: 10.1001/archgenpsychiatry.2011.1508. Epub 2012 Jan 2.

19.

Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review.

Undurraga J, Baldessarini RJ.

Neuropsychopharmacology. 2012 Mar;37(4):851-64. doi: 10.1038/npp.2011.306. Epub 2011 Dec 14. Review.

20.

Has adolescent suicidality decreased in the United States? Data from two national samples of adolescents interviewed in 1995 and 2005.

Wolitzky-Taylor KB, Ruggiero KJ, McCart MR, Smith DW, Hanson RF, Resnick HS, de Arellano MA, Saunders BE, Kilpatrick DG.

J Clin Child Adolesc Psychol. 2010;39(1):64-76. doi: 10.1080/15374410903401146.

Supplemental Content

Support Center